Vaxcyte, Inc. Common Stock Earnings Dividend

Vaxcyte, Inc. Common Stock’s revenue jumped NaN% since last year same period to $0Mn in the Q2 2026. On a quarterly growth basis, Vaxcyte, Inc. Common Stock has generated NaN% jump in its revenue since last 3-months.

Vaxcyte, Inc. Common Stock’s net profit fell -70.68% since last year same period to $-284.3Mn in the Q2 2026. On a quarterly growth basis, Vaxcyte, Inc. Common Stock has generated 11.33% jump in its net profits since last 3-months.

Vaxcyte, Inc. Common Stock’s net profit margin jumped NaN% since last year same period to -Inf% in the Q2 2026. On a quarterly growth basis, Vaxcyte, Inc. Common Stock has generated NaN% jump in its net profit margins since last 3-months.

Vaxcyte, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at 2 - a 236.05% jump from last quarter’s estimates.

Vaxcyte, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at 2.

Vaxcyte, Inc. Common Stock’s earning per share (EPS) fell -61.48% since last year same period to -1.97 in the Q2 2026. This indicates that the Vaxcyte, Inc. Common Stock has generated -61.48% annual rate of fall in its earning per share (EPS) in the last 4 quarters.